Saptarshi(Banerjee)BandyopadhyayMDAKA "Dr. Bandyo" and "Dr. B."(He/Him)

Internal Medicine • West Orange, NJ

Medical Scientist, Physician, and Consultant

Join to view full profile

Dr. Bandyopadhyay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bandyopadhyay's full profile

Already have an account?

Office
15 Whalen Court
West Orange, NJ 07052
Phone+1 908-372-8960

Education & Training

Case Western Reserve UniversityMS, Biomedical Engineering, 2021 - 2024
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2004 - 2006
University of Chicago (NorthShore)Residency, Internal Medicine, 2004 - 2006
McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2001 - 2002
University of Chicago (NorthShore)Internship, Transitional Year, 2001 - 2002
University of Illinois College of MedicineClass of 2001
University of Illinois at Urbana-ChampaignBS, Electrical Engineering - Bioengineering, With Highest Honors, 1991 - 1995
University of Illinois at Urbana-ChampaignBS, School of Life Sciences - Physiology, Magna Cum Laude, 1991 - 1995

Certifications & Licensure

NJ State Medical License 2016 - 2025
MI State Medical License 2009 - 2019
NY State Medical License 2007 - 2018
PA State Medical License 2016 - 2018
IL State Medical License 2004 - 2006
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Certificate of Recognition: Innovator Award DM Clinical Research, 2023
"Bravo" Award for Service Excellence Oakwood Hospital and Medical Center, 2012
Electrical Engineering Honor Society Eta Kappa Nu, 1993-1995
Engineering Honor Society Tau Beta Pi, 1993-1995
Academic Honor Society Phi Beta Kappa, 1993-1995
James Scholar University of Illinois at Urbana-Champaign, 1991-1995
Merit Ceremony Haldia Medical College (an ICARE Institution), 2007
Dean's List for 8 Eight semesters University of Illinois, 1991, 1992, 1993, 1994, 1995
Rockford Register Star “Young American” Award 1991
Join now to see all

Clinical Trials

Safety and Efficacy Study of Tesofensine/Metoprolol Treatment in Subjects With Type 2 Diabetes Mellitus Start of enrollment: 2016 Apr 01
Completed
Phase 2
Evaluation of Long Term Safety of Tesofensine in Patients With Obesity Start of enrollment: 2007 May 01
Completed
Phase 2

Publications & Presentations

Journal Articles

Ultrasound hyperthermia system for breast cancer treatment.
Burdette EC, Bandyopadhyay S, Proceedings of the IEEE Ultrasonics Symposium
Spatio-Temporal Modelling and Adaptive Acquisition for Cardiac MRI.
Aggarwal N, Bandyopadhyay S, and Y Bresler, Proceedings of the International Symposium on Biomedical Imaging

Books/Book Chapters

Toxico-terrorism: Emergency Response and Clinical Approach to Chemical, Biological, and Radiological Agents.
Chapter: Neurologic Issues
S Bandyopadhyay and M RezakEditors: JB Leikin and R MacFee.McGraw-Hill

Research History

InvestigatorNova 301: Phase III trial of mRNA 1403-P301 vaccine against Norovirus (Moderna).2024 - 2026
InvestigatorPhase II Trial of JCXH-105-021, RNA vaccine to prevent Shingles, compared to licensed Herpes Zoster Vaccine (Immorna Therapeutics).2022 - 2026
InvestigatorFluent: a Phase III trial of mRNA 1010-P301 for prevention of influenza (Moderna).2024 - 2025
Director, Clinical AffairsEarly Feasibility Study of J-Valve in High- & Intermediate-Risk Aortic Regurgitation (JC Medical).2022 - 2022
Medical Liaisonevoke/evoke+ trials, Phase III Clinical Trial to confirm the effect of oral GLP-1 receptor agonist Semaglutide for the treatment of mild cognitive impairment or mild dementia of Alzheimer’s Type (Novo Nordisk A/S).2022 - 2022
Protocol and Imaging Charter Committee MemberPhase III Trial of a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study of Surrogate Endpoints for Cardiovascular Risks with Treatment of Tesofensine versus Sibutramine in Overweight or Obese Subjects with Hypertension (NeuroSearch A/S).2008 - 2010
Protocol Committee Member, ANDA SubmissionPhase I Study to establish the bio-availability of controlled-release Naproxen granules compared to twice-a-day Naprosyn in adult patients (STI Pharma, LLC).2007 - 2009
Protocol Committee Member, NDA SubmissionPhase I/II Clinical Trial of the efficacy and safety of the PPAR-gamma partial agonist Balaglitazone in renal disease (Rheoscience AS).2007 - 2008
Co-InvestigatorPhase I/II Clinical Trial of "Eagle-Heart", a novel, manganese-based cardiac MRI contrast agent (Bracco Diagnostics and ImaRx Pharmaceuticals).2004 - 2006

Other Languages

Bengali, French, Spanish